Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Oxford BioDynamics Plc (LSE:OBD) Gains 9.09% as Precision Medicine and Diagnostic Innovation Accelerate

Oxford BioDynamics Plc (LSE:OBD) attracted notable investor attention after its shares advanced9.09%during trading on4 August 2026, placing the company among the day's stronger performers within the UK healthcare sector.

Ankur Sharma | 04 August 2026

Proteome Sciences plc (LSE:PRM) Climbs 11.11% as Precision Medicine and Biomarker Research Gain Momentum

Proteome Sciences plc (LSE:PRM) attracted strong investor attention after its shares advanced11.11%during trading on4 August 2026, placing the company among the leading gainers within the UK healthcare sector.

Ankur Sharma | 04 August 2026

ImmuPharma Surges 8.9%—Is the Market Waking Up to This Forgotten Stock?

Few names on London's junior market carry as much history, and as many bruises, as ImmuPharma (LSE: IMM). The clinical-stage drug developer, best known for its autoimmune candidate P140, once traded as a hopeful mid-cap on the strength of its lupus programme before a …

Ankur Sharma | 04 August 2026

Can Haleon plc Sustain Its Current Momentum?

Daily Change:-0.10p (down 0.03%) as of the latest session

Ishan Mudgal | 03 August 2026

Can GSK plc Sustain Its Current Momentum?

Daily Change:+15.50p (up 0.80%) as of the latest session

Ishan Mudgal | 03 August 2026

Can ConvaTec Group plc Sustain Its Current Momentum?

Daily Change:+5.20p (up 2.32%) as of the latest session

Ishan Mudgal | 03 August 2026

Can Smith & Nephew plc Sustain Its Current Momentum?

Daily Change:+36.00p (up 3.11%) as of the latest session

Ishan Mudgal | 03 August 2026

Aptamer Group plc Gains Momentum as Precision Medicine Innovation Accelerates

Aptamer Group plc was among the stronger-performing healthcare companies on the London market after its shares climbed approximately5.20%during trading on3 August 2026.

Ankur Sharma | 03 August 2026

CelLxHealth plc Gains Momentum: Everything Investors Need to Know About Today's Move

CelLxHealth plc attracted strong buying interest after its shares climbed approximately5.80%during trading on3 August 2026, placing the company among the stronger-performing healthcare stocks on the London market.

Ankur Sharma | 03 August 2026

LSE:FAB Surges on 3 August 2026: Why Investors Are Watching Fusion Antibodies PlcMeta Title:Why Did Fusion Antibodies Plc (LSE:FAB) Rise 5.44% on 3 August 2026?

Fusion Antibodies Plc attracted strong investor attention after its shares climbed approximately5.44%during trading on3 August 2026, making it one of the notable gainers among UK biotechnology companies.

Ankur Sharma | 03 August 2026
Support

Hi! How can we help you today?

Loading…